Newlink Genetics reported $79.48M in Market Capitalization for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agenus AGEN:US $ 1.22B 2.65M
Bristol Myers Squibb BMY:US $ 131.34B 17.15B
Capricor Therapeutics CAPR:US $ 92.55M 25.43M
Celldex Therapeutics CLDX:US $ 2.51B 1.18B
Eli Lilly And LLY:US $ 221.02B 902.49M
Idera Pharmaceuticals IDRA:US $ 54.34M 5.7M
Intrexon XON:US $ 1.03B 314.67M
Merk MRK:US $ 190131.55M 6786.63M
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Newlink Genetics NLNK:US $ 79.48M 4.1M
Pfizer PFE:US $ 241143.67M 21937.97M
Prothena PRTA:US 3.21B 937.65M
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Vascular Biogenics VBLT:US 127.86M 3.81M
YTE INCY:US $ 15.19B 3.31B